Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. Medicare pay-for-reporting effort draws fire from frustrated doctors 5. Debunking Myths in the US Healthcare System
Your Article Summary
See Latest ArticlesSynthetic carbohydrate-based anticancer vaccines: the Memorial Sloan-Kettering experience
Expert Review of Vaccines, 10/08/09
Zhu J et al. – The carbohydrate–based anticancer vaccine program has evolved through a number of stages: monomeric vaccines, monomeric clustered vaccines, unimolecular multi–antigenic vaccines and dual–acting vaccines. This account will focus on the recently developed unimolecular multi–antigenic constructs and potential dual–acting constructs, which contain clusters of both carbohydrate and peptide epitopes.
Related Articles
The glycobiology of brain tumors: disease relevance and therapeutic potential
Expert Review of Neurotherapeutics, 10/22/09
Relevance Score: 64%
CDC Survey Shows Gains in Overall Adolescent Vaccination Rates for 2008. But Majority Still Lack Immunizations for Tdap, MCV4
American Family Physician, 10/23/09
Relevance Score: 49%
A survey of adolescent experiences of human papillomavirus vaccination in the Manchester study
British Journal of Cancer, 10/09/09
Relevance Score: 49%
Human Papillomavirus Vaccine Uptake, Predictors of Vaccination, and Self-Reported Barriers to Vaccination
Journal of Women's Health, 10/05/09
Relevance Score: 48%
One Dose of H1N1 Vaccine Immunogenic in High Percentage of Youth Ages 10 to 17. Younger Children Likely Will Need Two Doses
American Family Physician, 10/05/09
Relevance Score: 48%
Today in Vaccine/Immunotherapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Evidence of Bias in Studies of Influenza Vaccine Effectiveness in Elderly Patients
The Journal of Infectious Diseases, 12/18/09
A Novel Influenza A (H1N1) Vaccine in Various Age Groups
New England Journal of Medicine, 12/17/09
Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine
New England Journal of Medicine, 12/17/09
Article Search
Sponsor